Assignee
OPTIPHARM CO LTD
KR·4 granted patents·4 pending applications·0 citations·filing 2013–2020
Top patents by PatentIndex Score
8 records- 0158US12077645B2Alginate microcapsules for cell encapsulation and, manufacturing method thereforOPTIPHARM CO LTD·Filed 2019·Granted Sep 3, 2024·0 cites·5 claims
- 0257US9469842B2Korean-type porcine reproductive and respiratory syndrome (PRRS) virusOPTIPHARM CO LTD·Filed 2014·Granted Oct 18, 2016·0 cites·11 claims
- 0342US10072302B2Cervical cancer diagnosing method and diagnostic kit for sameOPTIPHARM CO LTD·Filed 2013·Granted Sep 11, 2018·0 cites·5 claims
- 0442US2020131579A1Improved method for providing information on breast cancer and diagnostic kit thereforOPTIPHARM CO LTD·Filed 2014·Application pending·0 cites
- 0541US2022248647A1TRANSGENIC CLONED PIG FOR XENOTRANSPLANTATION EXPRESSING HUMAN CD46 AND TBM GENES, IN WHICH PORCINE ENDOGENOUS RETROVIRUS ENVELOPE C IS NEGATIVE AND GGTA1, CMAH, iGb3s AND ß4GalNT2 GENES ARE KNOCKED OUT, AND METHOD FOR PREPARING SAMEOPTIPHARM CO LTD·Filed 2020·Application pending·0 cites
- 0641US2016348181A1Quantitative reverse transcription polymerase chain reaction kit using tissue and blood for early diagnosis and screening test for therapeutic agent of breast cancerOPTIPHARM CO LTD·Filed 2013·Application pending·0 cites
- 0739US11655482B2Recombinant transition vector for increasing foreign protein expressionOPTIPHARM CO LTD·Filed 2018·Granted May 23, 2023·0 cites·9 claims
- 0836US2017211156A1Quantitative Reverse Transcription Polymerase Chain Reaction Kit for Breast Cancer Drug Screening Test and Early Diagnosis Using Tissue and BloodOPTIPHARM CO LTD·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →